CN101372677B - Bacillus and use thereof in aromatic ketone unsymmetrical reduction - Google Patents

Bacillus and use thereof in aromatic ketone unsymmetrical reduction Download PDF

Info

Publication number
CN101372677B
CN101372677B CN2008100424268A CN200810042426A CN101372677B CN 101372677 B CN101372677 B CN 101372677B CN 2008100424268 A CN2008100424268 A CN 2008100424268A CN 200810042426 A CN200810042426 A CN 200810042426A CN 101372677 B CN101372677 B CN 101372677B
Authority
CN
China
Prior art keywords
bacillus
application according
aryl ketones
asymmetric reduction
prochirality
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008100424268A
Other languages
Chinese (zh)
Other versions
CN101372677A (en
Inventor
许建和
谢谚
徐毅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
East China University of Science and Technology
Original Assignee
East China University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by East China University of Science and Technology filed Critical East China University of Science and Technology
Priority to CN2008100424268A priority Critical patent/CN101372677B/en
Publication of CN101372677A publication Critical patent/CN101372677A/en
Application granted granted Critical
Publication of CN101372677B publication Critical patent/CN101372677B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a bacillus (Bacillus sp ECU0013) with the culture collection number being CGMCC No. 2549, and the application of the bacillus which is taken as a catalyst to reduce prochiral arone. The bacterial strain bacillus (Bacillus sp ECU0013) has the advantages that the selectivity is high, the substrate tolerance is high, the bacillus can help coenzyme to regenerate by glucose, thepreparation is easy, and the like, which is an efficient strain expected to be used in industrial production.

Description

Genus bacillus and the application in the aryl ketones asymmetric reduction thereof
Technical field
The present invention relates to bacillus and uses thereof, more particularly relate to the method that this genus bacillus catalytic asymmetric reduction prochirality aryl ketones obtains optical pure chiral aryl alcohol.
Background technology
Chirality is nature and organic important phenomenon, and along with to the going deep into of chirality phenomenon research, increasing single enantiomer is applied to medicine, essence and flavoring agent, agricultural chemicals and LCD product.The chiral centre of chiral alcohol is connected to an active functional group " OH ", makes such material become the key intermediate of many quiral products when synthetic.The aryl chiral alcohol be many medicines important chiral intermediate, for example: 2-chloro-1-phenylethyl alcohol is exactly synthetic fluoxetine (Fluoxetine), the important as precursors of tomoxetine (Tomoxetine) and nisoxetine (Nisoxetine).Fluoxetine (Fluoxetine) also is a kind of potent thymoleptic, and to many illnesss, as anxiety, alcoholism, chronic pain, obesity, gluttony, apocleisis better curative effect is arranged all.Tomoxetine (Tomoxetine) is the first NRI, with α-or β-adrenergic receptor do not have strong bonding force, be a kind of thymoleptic, the drug effect of its (R)-(-)-isomer is than 9 times of its mapping heights.By the asymmetric reduction of biocatalysis prochirality carbonyl compound, can obtain the chiral alcohol of theoretical yield 100%, have very important theory significance and application prospect.Though chemical catalysis has been obtained certain progress, biocatalysis has caused extensive concern with its highly selective, security and advantages of environment protection.But the reduction reaction of biocatalysis also exists in actual production challenges such as the substrate tolerance is low, regenerating coenzyme costliness, make present redox enzymes biological catalyst realize that the ratio of industrial application is less than 14%, the industrial application rate is very low, and the true tumor catalyzer of therefore seeking excellent performance is one of effective way of development biological reducing.
Summary of the invention
One of the object of the invention is, the bacterial strain of the multiple prochirality aryl ketones of a kind of energy asymmetric reduction is provided;
Two of the object of the invention is, a kind of method of using above-mentioned bacterial strains asymmetric reduction prochirality aryl ketones is provided.
The present inventor is from soil, through primary dcreening operation, multiple sieve and separation and purification, obtain the genus bacillus (Bacillus sp.ECU0013) of strain energy asymmetric reduction prochirality aryl ketones, this bacterial strain is preserved in China Committee for Culture Collection of Microorganisms common micro-organisms center (CGMCC) on June 18th, 2008, and preserving number is: CGMCC No.2549.
Bacillus sp.ECU0013 (CGMCC No.2549) has following feature:
1. size and form
Shaft-like, size 2~3 μ m, Gram-negative;
2. be fit to growing environment
Can survive in pH5~9 environment 10~40 ℃ of temperature;
3. the dull and stereotyped colony characteristics of cultivating
Concentric circles; Prominent umbilical; Faint yellow.
The technical solution used in the present invention:
The screening method of catalysis aryl ketones asymmetric reduction bacterial classification may further comprise the steps: from gathering soil sample in the zone as far as possible widely, and the moistening soil layer collection that soil sample should be below underground 5cm; (2~10mM) substrate is as carbon source, and after the adding soil sample, in 30 ℃, 160rpm cultivates 1-6d for dress 50mL liquid nutrient medium A and finite concentration in the Erlenmeyer flask of 250mL.Afterwards this nutrient solution is coated on the solid medium B, cultivated 3d for 30 ℃, the single bacterium colony that grows carries out the plate streaking separation and purification.
Identify that through 16S rDNA confirm that this bacterial strain is genus bacillus (Bacillus sp.), label is Bacillus sp.ECU0013.
Bacterial strain of the present invention can be used as catalyzer, asymmetric reduction prochirality aryl ketones, and production method comprises the following steps:
1. the cultivation of bacterial strain
With the method for described bacillus sp.ECU0013 employing this area routine, in fermention medium, carry out amplification cultivation 8~24h, 20~40 ℃ of temperature; Again with this nutrient solution as seed, be 1~10% (v/v) based on the inoculum size of fermention medium volume, be seeded in the fermention medium, cultivate 24~48h, the centrifugal resting cell that obtains on the shaking table of 100~160rpm down at 20~40 ℃;
Described fermention medium can adopt conventional substratum, and its components contents is as follows: dextrin 10~50g, yeast extract paste 5g/L, peptone 1~20g, KH 2PO 41~10g, K 2HPO 41~10g, NaCl0.1~2g, MgSO 40.1~2g, water 1000ml, pH3~8.
Resting cell with results, be suspended in pH and be in 6.0~9.0 the phosphate buffer solution, add prochiral substrate aryl ketones, concentration is 1~200mM, constant temperature shaking table oscillatory reaction 3~96h at 20~50 ℃ and 100~160rpm collects product then from reaction system.The content of resting cell in phosphoric acid buffer is 10~500g (weight in wet base)/L.
Beneficial effect of the present invention: the present invention's screening obtains a bacillus as catalyzer, asymmetric reduction prochirality aryl ketones, have the stereoselectivity height, the substrate tolerance is strong, and can be by advantages such as cheap glucose realization regenerating coenzymes, biological catalyst is easy to preparation in addition, the reaction conditions gentleness has certain industrial application DEVELOPMENT PROSPECT.The 2-chloro-1-methyl phenyl ketone that reducible in an embodiment concentration is 50mM, the transformation efficiency of reaction reaches more than 90%, enantiomeric excess value (e.e.) still keeps〉99%.
Embodiment
By the following examples technology contents of the present invention is further described.Its purpose only is to understand content of the present invention better, and unrestricted protection scope of the present invention.
Embodiment 1
The screening of bacterial strain
Bacillus cell of the present invention (Bacillus sp.ECU0013) is a kind of bacterial strain that belongs to the bacterium Bacteroides, and this bacterial strain system separates from soil, obtains through behind the multi-turns screen.According to 16S rDNA molecular biology identification result, the homology of this bacterium and genus bacillus (Bacillus sp.) is 99%.
The method of screening above-mentioned aryl ketones asymmetric reduction bacterial strain is: from gathering soil sample in the zone as far as possible widely, and the moistening soil layer collection that soil sample should be below underground 5cm; (2~10mM) substrate is as carbon source, and after the adding soil sample, in 30 ℃, 160rpm cultivates 1-6d for dress 50mL liquid nutrient medium A and finite concentration in the Erlenmeyer flask of 250mL.Afterwards this nutrient solution is coated on the solid medium B, cultivated 3d for 30 ℃, the single bacterium colony that grows carries out the plate streaking separation and purification.The culture medium A of using is: (NH 4) 2SO 42g/L, KH 2PO 42g/L, yeast extract paste 2g/L, NaCl1g/L, MgSO 40.2g/L, mixed trace elements (CoCl 20.28g/L, ZnSO 47.0g/L, MnSO 4H 2O1.1g/L, CuSO 40.48g/L, EDTANa 22H 2O15.8g/L, FeSO 47H 2O1.6g/L, Na 2MoO 42H 2O0.34g/L, pH7.2); Substratum B is: glucose 15g/L, Na 2HPO 40.5g/L, peptone 5g/L, NaH 2PO 40.5g/L, yeast extract paste 5g/L, MgSO 40.5g/L, NaCl1g/L, pH7.0; The substrate aryl ketones is a 2-chloro-1-methyl phenyl ketone.
With single colony inoculation of obtaining in liquid nutrient medium B, at 30 ℃, after 160rpm cultivated 48h, (0.1~0.5g) was suspended in 1mL phosphoric acid buffer (PBS, 50mM to get a certain amount of wet cell, pH7.0) in, add substrate 2-chloro-1-methyl phenyl ketone (10mM is with the ethanol hydrotropy) and 5% glucose, at 30 ℃, 1, react 24h under the 100rpm condition.After reaction finishes, use thin plate chromatography (TLC) assay products/substrate ratio, select the high bacterial strain of proportion of products to carry out multiple sieve.
In the multiple sieve, the cultural method and the reaction conditions of thalline are the same, centrifugal after the reaction end (12,000rpm, 5min), the supernatant liquor of collection is got upper organic phase with ethyl acetate extraction twice, uses anhydrous Na 2SO 4Dried overnight is carried out gas chromatographic analysis, measures product content and enantiomeric excess (e.e.) value.
The selection result is that the bacterial strain catalysis biological when reduction product that is numbered ECU0013 has high enantiomeric excess value.
Determine that through gramstaining selected bacterial strain is a gram negative bacterium, use 16S rDNA method to carry out strain identification.
Bacterial strain ECU0013 is carried out single bacterium colony cultivate, extract total DNA afterwards, electrophoresis detection.
With total DNA is template pcr amplification goal gene: 30 μ L systems, dna profiling 4 μ L, each 1 μ L of universal primer, Buffer3 μ L, dNTP2 μ L (2.5mM), Taq enzyme 1 μ L, distilled water 18 μ L.
Figure G2008100424268D00041
Electrophoresis determines that carrying out goal gene after the amplification gene size correctly reclaims, and electrophoresis confirms that the gene that reclaims is correct.
Connect: 10 μ L systems connect liquid 5 μ L, T carrier (pUC18) 1 μ L, PCR product 4 μ L.16 ℃ connect 16h.
Transform: goal gene is transformed into bacillus coli DH 5 alpha.
The Lan Bai screening is selected white single bacterium and is cultivated, and the bacterium liquid that obtains carries out bacterium colony PCR as template, and condition is the same.Send to order-checking after the gene electrophoresis detection that obtains.
Sequencing result is
CGGTACCCGGGGATCCTCTAGAGATTAGAGTTTGATCCTGGCTCAGG
ACGAACGCTGGCGGCGTGCCTAATACATGCAAGTCGAGCGGACAGATGGG
AGCTTGCTCCCTGATGTTAGCGGCGGACGGGTGAGTAACACGTGGGTAACC
TGCCTGTAAGACTGGGATAACTCCGGGAAACCGGGGCTAATACCGGATGGT
TGTTTGAACCGCATGGTTCAAACATAAAAGGTGGCTTCGGCTACCACTTAC
AGATGGACCCGCGGCGCATTAGCTAGTTGGTGAGGTAATGGCTCACCAAGG
CAACGATGCGTAGCCGACCTGAGAGGGTGATCGGCCACACTGGGACTGAG
ACACGGCCCAGACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCGCAATG
GACGAAAGTCTGACGGAGCAACGCCGCGTGAGTGATGAAGGTTTTCGGAT
CGTAAAGCTCTGTTGTTAGGGAAGAACAAGTACCGTTCGAATAGGGCGGTA
CCTTGACGGTACCTAACCAGAAAGCCACGGCTAACTACGTGCCAGCAGCC
GCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGGG
CTCGCAGGCGGTTTCTTAAGTCTGATGTGAAAGCCCCCGGCTCAACCGGGG
AGGGTCATTGGAAACTGGGGAACTTGAGTGCAGAAGAGGAGAGTGGAATT
CCACGTGTAGCGGTGAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGA
AAGCGACTCTCTGGTCTGTAACTGACGCTGAGGAGCGAAAGCGTGGGGAG
CGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGAGTGCTAA
GTGTTAGGGGGTTTCCGCCCCTTAGTGCTGCAGCTAACGCATTAAGCACTC
CGCCTGGGGAGTACGGTCGCAAGACTGAAACTCAAAGGAATTGACGGGGG
CCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAAC
CTTACCAGGTCTTGACATCCTCTGACAATCCTAGAGATAGGACGTCCCCTTC
GGGGGCAGAGTGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAG
ATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGATCTTAGTTGCCAGC
ATTCAGTTGGGCACTCTAAGGTGACTGCCGGTGACAAACCGGAGGAAGGT
GGGGATGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCT
ACAATGGACAGAACAAAGGGCAGCGAAACCGCGAGGTTAAGCCAATCCC
ACAAATCTGTTCTCAGTTCGGATCGCAGTCTGCAACTCGACTGCGTGAAGC
TGGAATCGCTAGTAATCGCGGATCAGCATGCCGCGGTGAATACGTTCCCGG
GCCTTGTACACACCGCCCGTCACACCACGAGAGTTTGTAACACCCGAAGT
CGGTGAGGTAACCTTTTAGGAGCCAGCCGCCGAAGGTGGGACAGATGATT
GGGGTGAAGTCGTAACAAGGTAGCCGTAAATCGTCGACCTGCAGGCATGC
AAGCTtG
Through sequence alignment, the homology of this bacterium and genus bacillus (Bacillus sp.) is 99%.Name the sp.ECU0013 for Bacillus, and be preserved in China Committee for Culture Collection of Microorganisms common micro-organisms center (CGMCC) on June 18th, 2008, preserving number is: CGMCC No.2549.
Embodiment 2
With the method for described bacillus sp.ECU0013 employing this area routine, in fermention medium, carry out amplification cultivation 8~24h, 20~40 ℃ of temperature;
Again with this nutrient solution as seed, be 1~10% (v/v) based on the inoculum size of fermention medium volume, be seeded in the fermention medium, cultivate 24~48h, the centrifugal resting cell that obtains on the shaking table of 100~160rpm down at 20~40 ℃;
Said fermention medium can adopt conventional substratum, and its components contents is as follows: dextrin 10~50g, yeast extract paste 5g/L, peptone 1~20g, KH 2PO 41~10g, K 2HPO 41~10g, NaCl0.1~2g, MgSO 40.1~2g, water 1000ml, pH3~8.
Embodiment 3~14
Get a certain amount of above-mentioned cultivation the genus bacillus wet cell (0.1~0.5g) be suspended in the 1mL phosphoric acid buffer (PBS, 50mM, pH7.0) in, add the substrate methyl phenyl ketone (10 of 5% glucose and different concns, 30,50,100,150,200mM is with the ethanol hydrotropy) or 2-chloro-1-methyl phenyl ketone (10,30,50,100,150,200mM is with the ethanol hydrotropy), at 30 ℃, 1, react certain hour under the 100rpm condition.Centrifugal after the reaction end (12,000rpm, 5min), the supernatant liquor of collection adds ethyl acetate extraction twice, gets upper organic phase, uses anhydrous Na 2SO 4Dried overnight is carried out gas-chromatography (adopting island functional activities of the body fluid chromatography GC-14, chiral capillary column SUPCOL DEX β-120) and is analyzed, and measures the content and enantiomeric excess (e.e.) value of product.
Figure G2008100424268D00061
Figure G2008100424268D00071
Embodiment 15~23
Get a certain amount of above-mentioned cultivation the genus bacillus wet cell (0.01~0.5g) be suspended in the 1mL phosphoric acid buffer (PBS, 50mM, pH7.0) in, add 5% glucose and different substrates (10mM is with the ethanol hydrotropy), at 30 ℃, 1, react certain hour under the 100rpm condition.Centrifugal after the reaction end (12,000rpm, 5min), the supernatant liquor of collection is got upper organic phase with ethyl acetate extraction twice, uses anhydrous Na 2SO 4Dried overnight is carried out gas-chromatography (adopting island functional activities of the body fluid chromatography GC-14, chiral capillary column SUPCOL DEX β-120) and is analyzed, and measures the content and enantiomeric excess (e.e.) value of product.
Figure G2008100424268D00081
Embodiment 24
The genus bacillus wet cell of getting the above-mentioned cultivation of 10g be suspended in the 100mL phosphoric acid buffer (PBS, 50mM, pH8.0) in, add 5% glucose and 1g2-chloro-1-methyl phenyl ketone (with the ethanol hydrotropy), at 30 ℃, reaction is 24 hours under the mechanical stirring condition.Reaction finish the back centrifugal (8,000rpm, 10min), the supernatant liquor of collection with ethyl acetate extraction three times after, add saturated NaCl solution again and wash once.Get upper organic phase, use anhydrous Na 2SO 4Dried overnight, use silica gel column chromatography (eluent is: petrol ether/ethyl acetate: 2:1~10:1, v/v) after, vacuum-drying product (R)-2-chloro-1-phenylethyl alcohol.Product can be used gas-chromatography (adopting island functional activities of the body fluid chromatography GC-14, chiral capillary column SUPCOL DEX β-120) assay determination enantiomeric excess (e.e.) value.
Yield: 71.8%; Ee:〉99.9%; [α] D 25=-48.8 (c1.00, CHCl 3).

Claims (10)

1. a plant height is imitated catalysis aryl ketones asymmetric reduction bacterial classification, and genus bacillus (Bacillussp.) ECU0013 is preserved in China Committee for Culture Collection of Microorganisms common micro-organisms center (CGMCC), and preserving number is CGMCC No.2549.
2. a bacterial strain as claimed in claim 1 is as the application of catalyzer in the asymmetric reduction aryl ketones.
3. bacterial strain as claimed in claim 2 is characterized in that comprising the step of following biological reducing prochirality aryl ketones as the application of catalyzer in the asymmetric reduction aryl ketones:
A. the fermentation culture preserving number is the genus bacillus (Bacillus sp.) of CGMCC No.2549, centrifugal acquisition resting cell; Resting cell is suspended in the buffered soln that has added glucose;
B. in above-mentioned buffered soln, add the prochirality aryl ketones, add the organic cosolvent of reaction system volume 1%~20%, produce corresponding optical pure chiral aryl alcohol through asymmetric reduction reaction;
C. reaction solution through separate, purifying obtains target product optical purity (S)-or (R)-aryl alcohol.
4. application according to claim 3 is characterized in that: described fermention medium component of step a and content are as follows: dextrin 10~50g, peptone 1~20g, KH 2PO 41~10g, K 2HPO 41~10g, NaCl 0.1~2g, MgSO 40.1~2g, water 1000ml, pH 3~8.
5. application according to claim 3 is characterized in that: the resting cell concentration of genus bacillus described in the step a is counted 10~500g/L with weight in wet base.
6. application according to claim 3 is characterized in that: the concentration of prochirality aryl ketones is 1~200mM described in the described reaction system of step b.
7. application according to claim 3 is characterized in that: the described asymmetric reduction reaction temperature of step b is 20~50 ℃, and the reaction times is 3~96 hours.
8. application according to claim 3 is characterized in that: the described buffered soln of step a is the phosphate buffer solution of pH 6~9, and the addition of glucose is 1~10% mass concentration.
9. application according to claim 3 is characterized in that: the described organic cosolvent of step b is selected from one or more the mixture in methyl alcohol, ethanol, dimethyl sulfoxide (DMSO) or the dimethyl formamide.
10. application according to claim 3 is characterized in that: the structural formula of described prochirality aryl ketones is:
Figure FSB00000012063400021
(1) R in 1Elect as-Cl ,-Br or-OCH 3R 2Elect as-CH 3,-C 2H 5,-CH 2Cl or-CH 2Br;
(2) Ar elects 2-pyridyl, 3-pyridyl, 4-pyridyl or 2-thienyl as in.
CN2008100424268A 2008-09-03 2008-09-03 Bacillus and use thereof in aromatic ketone unsymmetrical reduction Expired - Fee Related CN101372677B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008100424268A CN101372677B (en) 2008-09-03 2008-09-03 Bacillus and use thereof in aromatic ketone unsymmetrical reduction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008100424268A CN101372677B (en) 2008-09-03 2008-09-03 Bacillus and use thereof in aromatic ketone unsymmetrical reduction

Publications (2)

Publication Number Publication Date
CN101372677A CN101372677A (en) 2009-02-25
CN101372677B true CN101372677B (en) 2010-06-16

Family

ID=40447056

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008100424268A Expired - Fee Related CN101372677B (en) 2008-09-03 2008-09-03 Bacillus and use thereof in aromatic ketone unsymmetrical reduction

Country Status (1)

Country Link
CN (1) CN101372677B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102559623B (en) * 2010-10-29 2014-02-12 华东理工大学 Reductase, gene and recombinase of reductase and preparation method and application of recombinase

Also Published As

Publication number Publication date
CN101372677A (en) 2009-02-25

Similar Documents

Publication Publication Date Title
CN101372676B (en) A strain of Rhodococcus and use thereof for preparing optical pure chiral sulphoxide
US11085059B2 (en) Methylopila sp. and use thereof in selective resolution preparation of (S)-α-ethyl-2-oxo-1-pyrrolidineacetate
CN101230363A (en) Method for preparing (R)-styrene glycol by employing asymmetric conversion of recombinant strain
CN101857887B (en) Method for preparing optically pure aryl alcohol with cell-free extracts of recombinant strains by catalytic asymmetric conversion
CN110760449B (en) Geotrichum galactose ZJPH1810 and application thereof in preparation of (S) -1- (2, 6-dichloro-3-fluorophenyl) ethanol
CN101372677B (en) Bacillus and use thereof in aromatic ketone unsymmetrical reduction
CN100489085C (en) Red yeast cell and method of producing optically pure chiral tertiary alcohol
CN102851238B (en) Sphingobacterium and method for preparing levetiracetam acid by utilizing same
CN105567584B (en) A kind of (+/-) gamma-lactam that can split obtains bacillus and its screening and application of (+) gamma-lactam
CN103589665B (en) Celebrating sheng, a reed pipe wind instrument rhodococcus and the application in preparation (S)-4-chloro-3-hydroxyl ethyl butyrate thereof
CN101824438B (en) Method for preparing (S)-3-hydroxy butyric acid ethyl ester through ethyl acetoacetate microbial conversion
CN106086090B (en) A kind of method that two-step microbial conversion method prepares R-MA
CN103074239B (en) Candida sorboxylosa and application thereof in preparation of (S)-4-chloro-3-hydroxybutanoate
CN102757924B (en) Rhodococcus and application thereof in preparation of (S)-(+)-2,2-dimethylcyclopropane carboxylic acid
CN101358183B (en) Red bean carbonyl reductase, preparation method and use thereof
CN106754560B (en) Bacillus albus zjut528 and the application in fractionation metalaxyl
CN104561136B (en) A kind of method that raceme aryl vicinal diamines are converted into chiral aryl vicinal diamines
CN101586128B (en) Method for catalyzing, reducing and producing (R)-4-substituent phenethyl alcohol utilizing Acetobacter
CN102952760B (en) Rhodococcus erythropolis capable of converting quininone into (S)-3-quinuclidinol and conversion method
CN116121158B (en) Genetic engineering strain for producing (R, R) -2, 3-butanediol, acetoin and tetramethylpyrazine and application thereof
CN102643879B (en) Method for preparing duloxetine chiral intermediate through microbial conversion
CN100371451C (en) Preparation of effective mycoenamine with microbial lytic acrose and its derivative
CN105039429A (en) Method for biologically producing (S)-metoxybenzene alcohol
CN105039430A (en) Method for producing (S)-fluobenzene ethanol through candida
CN104263767A (en) Method for producing iodophenyl methyl propionate through reduction by virtue of candida utilis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100616

Termination date: 20120903